Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma (Q33358646)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma |
scientific article |
Statements
1 reference
Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma (English)
1 reference
Hagop Kantarjian
1 reference
Elias Anaissie
1 reference
Guillermo Garcia-Manero
1 reference
Maurizio Zangari
1 reference
Maher Albitar
1 reference
Francis J Giles
1 reference
Jeffrey Lancet
1 reference
Stephan Faderl
1 reference
Alison Hannah
1 reference
Alison Stopeck
1 reference
Julie Cherrington
1 reference
Alyssa Morimoto
1 reference
Nguyen Tan
1 reference
Maureen Cooper
1 reference
1 January 2004
1 reference
1 reference
Identifiers
1 reference